iMENOR 10 mg is a prescription cytotoxic and immunosuppressant medicine in the form of divisible tablets containing methotrexate (as methotrexate disodium). This is a French-market pack of 10 tablets. The marketing-authorisation holder is Orion Corporation (Espoo, Finland) and the tablets are manufactured by Orion Corporation, Orion Pharma (Turku or Salo, Finland); the product is distributed in France by Nordic Pharma, Paris.
According to the French summary of product characteristics, iMENOR is indicated for: active rheumatoid arthritis in adults; severe, disabling, recalcitrant psoriasis that has not responded adequately to other treatments such as phototherapy, PUVA therapy and retinoids, and severe psoriatic arthritis in adults; and maintenance treatment of acute lymphoblastic leukaemia in adults, adolescents and children from 3 years of age.
For rheumatic diseases, psoriasis and psoriatic arthritis, methotrexate is taken ONCE A WEEK, on the same day each week. A mistake in the dose can cause serious, potentially fatal adverse reactions. The prescribing doctor sets the day of intake and writes it on the prescription.
Regular monitoring is mandatory: blood count, liver and kidney tests (weekly during the first weeks, then at the intervals your doctor sets), plus examination of the mouth and throat. Folic or folinic acid may be prescribed to reduce side effects (digestive symptoms, sore mouth, hair loss, raised liver enzymes), but vitamin preparations containing folic acid or folinic acid can also reduce the effect of methotrexate — take them only if your doctor prescribes them.
Most of the reactions listed below are less frequent and less severe at the low doses used in rheumatology and dermatology than at the high doses used in cancer treatment, but serious reactions can occur even at low doses.
Seek medical help immediately if you develop a fever, a persistent dry cough or breathlessness, black or bloody stools, vomiting of blood, mouth ulcers that do not heal, or any severe skin reaction.
Shelf life 3 years. No special storage conditions as regards temperature; keep the blister in the outer carton, protected from light. Do not use after the expiry date shown on the blister and the carton (the last day of that month). Unused medicine and waste must be disposed of in accordance with the rules for cytotoxic agents.
The pack photo is shown for identification purposes; packaging design and leaflet language may vary between markets. This text summarises the official French product information (RCP and patient leaflet, ANSM) and is not a substitute for the advice of your doctor or pharmacist. iMENOR is a prescription cytotoxic medicine and must be used only under medical supervision.
📦 Ask about availability and delivery to your country on WhatsApp
